Novus Diagnostics raises €5m to build next-generation rapid test for Sepsis

Novus Diagnostics raises €5m to build SepTec, analysing blood samples and diagnoses life-threatening bloodstream infections in just 15 minutes.

By Danielle Norton November 21, 2022 Updated February 20, 2024 3 min read

Irish MedTech firm Novus Diagnostics is today (Monday, November 21) announcing that it has secured €5m in new equity financing. This follows €2.4m in funding from the European Innovation Council in 2020, bringing the total funds raised by the company to €7.4m.